David J. Chang - Jan 18, 2023 Form 4 Insider Report for Cabaletta Bio, Inc. (CABA)

Role
Chief Medical Officer
Signature
By: /s/ Michael Gerard, as Attorney-in-Fact
Stock symbol
CABA
Transactions as of
Jan 18, 2023
Transactions value $
$0
Form type
4
Date filed
1/27/2023, 07:48 PM
Previous filing
Jan 19, 2022
Next filing
Mar 4, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CABA Stock Option (Right to Buy) Award $0 +150K $0.00 150K Jan 18, 2023 Common Stock 150K $11.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option shall vest and become exercisable on January 18, 2024, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date.